Migraine clinical trials
76 active trials name this condition. Describe your situation to see which ones you may be eligible for.
By location
- A Study to Learn About the Safety of Taking an Additional Dose of the Medicine Rimegepant in Adults With Migraine
- A Feasibility Trial of Virtual Reality Neurofeedback for Adolescents With Migraine
- Effectiveness of Magnesium in Addition to Prochlorperazine for the Treatment of Migraines
- RELAXaHEAD for Headache Patients (Phase III)
- Mind Body Intervention for Chronic Migraine Headaches
- Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
- Mind Body Balance for Pediatric Migraine
- Does Nerve Block + Oral Dexamethasone Reduce Recurrence of Headache Within 72 Hrs?
- Machine Learning in Guiding rTMS Treatment for GWI-Related Headaches and Body Pain
- Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study
- Randomized Study in Children and Adolescents With Migraine: Acute Treatment
- A Study to Learn About the Study Medicine Called Zavegepant (PF-07930207) in Children With a History of Migraine
- A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine
- Qudexy XR for the Prevention of Migraine in Children 6 to 11 Years Old
- Responding With Evidence and Access for Childhood Headaches
- Bilateral Middle Meningeal Artery Lidocaine Infusion for Chronic Debilitating Migraines
- Effectiveness and Tolerability of Zavegepant for Acute Migraine Treatment Among Those Using CGRP Targeting Preventive Medications
- Stimulation of External Carotid Artery Circulation
- Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
- A Study of Eptinezumab in Pediatric Participants With Episodic Migraine
- A Comparison of Nurtec ODT to Maxalt MLT-ODT in Adult ED Patients With Migraine Headache
- Ultrasound Guided Radiofrequency Ablation of the Occipital Nerve
- Bilateral Embolization of the Middle Meningeal Arteries for Refractory Chronic Migraine
- Clinical Trial of Endoscopically Guided Injection of Exparel (Bupivacaine) for the Treatment of Craniofacial Pain
- Study of EVO756 in Adults With Migraine
- Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
- Rimegepant as Preemptive Treatment for Predictable Trigger-Induced Migraine in Adult Patients in the US
- A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migraine
- Objectively Diagnose and Monitor Treatment of Light Sensitivity
- Study VFC202-201 is a Randomized, Double-blind, Placebo-controlled, Crossover, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of ASY202 (Dihydroergotamine Mesylate [DHE] Inhalation Powder Delivered Via a Multidose Dry Powder Inhaler) for the Acute Treatment of Migraine
- A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
- A Comprehensive Digital Care Program for Migraine Management
- Study to Assess the Real-World Effectiveness of Ubrogepant in Adult Participants When Treating During the Prodrome Phase of Migraine Attacks
- Real-world Prospective Study on the Use of Anti-CGRP Drugs in Migraine
- External Trigeminal Nerve Stimulation for Migraine Treatment in Pregnancy
- Endometriosis and Migraine
- Puberty, Testosterone, and Brain Development
- Aimovig Pregnancy Exposure Registry
- Emgality for Migraine in Breastmilk
- Observational Study to Assess Adverse Events When Adult Female Participants Are Treated With Ubrelvy (Ubrogepant) or Qulipta (Atogepant) During Pregnancy
- Observational Study to Assess Maternal, Fetal and Infant Outcomes Following Exposure to Rimegepant
- Efficacy of Xeomin for Migraines in Patients With Traumatic Brain Injuries vs. Anomalous Health Incidents
- Overlapping Pain Trajectory Study
- Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research
- Analysis of Headache Chronification With Imaging, Deep Phenotyping, and Proteomics
- MMA Embolization for Refractory Chronic Migraine
- Light Exposure, Migraine Outcomes, and Sleep Quality
- Migraine in Adolescents
- Mechanistic Studies of Psilocybin in Headache Disorders
- Cocoa Extract for Migraine Trial
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Migraine” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.